Infectious Disease Diagnostics – News and Features

How can you identify which technique is best suited to your research requirements? In this article, we explore the advantages of qPCR and dPCR, considering specific applications and deliverable metrics to help you choose the right technology to suit your experimental needs.

New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.

Composite polymer particles adorned with gold nanoparticles could improve the accuracy of infectious disease testing, reports a new study.

Scientists have developed a novel blood test to measure the immune response to the Epstein-Barr virus, the leading risk factor for developing multiple sclerosis. The test has the potential to be applied in clinical trials that target the virus.

A team of researchers at Tohoku University has reported on a high-performance magnesium-air (Mg-air) battery that is paper-based and activated by water.

Scientists have taken a major step towards developing a blood test that could identify millions of people who spread tuberculosis unknowingly.

CRISPR-based test detects a genetic target that is specific to Burkholderia pseudomallei, the bacterium that causes melioidosis, with 93% sensitivity.

MIT chemists have designed a sensor that detects tiny quantities of perfluoroalkyl and polyfluoroalkyl substances (PFAS) — chemicals found in food packaging, nonstick cookware, and many other consumer products.

Leptospirosis is a globally distributed infectious disease that affects both animals and humans. The serological diagnostic test performs better when local variants are used.

A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis.